News
Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...
An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who ...
The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.
Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of ...
Cancer patients must speak to their doctor before taking weight-loss jabs, a British charity has warned, amid a rise in people seeking help over whether they can take them.Macmillan Cancer Support ...
The S&P 500 advanced 1% on Monday, June 23, 2025, as investors weighed the potential severity and impact of Iran's retaliation for U.S. airstrikes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results